|
|
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data
Sébastien Bailly
,
Olivier Leroy
,
Philippe Montravers
,
Jean-Michel Constantin
,
Hervé Dupont
et al.
Journal articles
hal-01205360v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Suspicion de péritonite à Candida dans l’étude AMARCAND II : peut-on prédire les patients qui vont avoir une culture positive ?
Hervé Dupont
,
Philippe Montravers
,
Jean-Pierre Gangneux
,
Élie Azoulay
,
Jean-Michel Constantin
et al.
Journal articles
hal-01244999v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Patient factors and outcomes associated with the withdrawal or withholding of life-sustaining therapies in mechanically ventilated brain-injured patients An observational multicentre study
Marine Hubert
,
Sonia Isslame
,
Pierre-François Perrigault
,
Thomas Geeraerts
,
Olivier Mimoz
et al.
Journal articles
hal-01834090v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: a post-hoc causal inference model using the AMARCAND2 study
Sébastien Bailly
,
Olivier Leroy
,
Elie Azoulay
,
Philippe Montravers
,
Jean-Michel Constantin
et al.
Journal articles
hal-01632852v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study
Olivier Leroy
,
Sébastien Bailly
,
Jean-Pierre Gangneux
,
Jean-Paul Mira
,
Patrick Devos
et al.
Journal articles
hal-01259216v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|